Desferrioxamine Mesylate

Therapeutic Group

All Other Therapeutic Products, Anti-dotes

Indication Dosage

Acute Iron Poisoning, Haemochromatosis, Aluminium Overload In Dialysis Patients: 

  • Adults & Children: See Literature.

Content

  • Inj 250mg /500mg: Desferrioxamine Mesylate 250mg /500mg; Powder In Vial
  • Tab 125mg /250mg /500mg: Desferrioxamine Mesylate 125mg /250mg /500mg

Pregnancy

Consult with Doctor Or Caution Advised

Stability

  • Chelating Agent

Contra Indications

  • Hypersensitivity To Desferrioxamine.

Precautions

  • Hypersensitivity To Desferrioxamine.

Lactation

  • Consult with Doctor Or Caution Advised

Side Effects

  • Abdominal Distension And Pain
  • Headache
  • Constipation
  • Diarrhoea
  • Dyspepsia
  • Gi Haemorrhage And Ulceration
  • Nausea
  • Vomiting
  • Proteinuria
  • Pruritus
  • Raised Serum Creatinine
  • Raised Transaminases
  • Rash
  • Anxiety
  • Cataract
  • Cholelithiasis
  • Disturbances Of Hearing And Vision
  • Dizziness
  • Fatigue
  • Gastritis
  • Glucosuria
  • Hepatitis
  • Laryngeal Pain
  • Maculopathy
  • Oedema
  • Pyrexia
  • Renal Tubulopathy
  • Skin Pigmentation
  • Sleep Disorder.
  • Rare: Oesophagitis
  • Optic Neuritis